Join us for the Policy Summit Sept. 25-26 at the Washington Marriott Georgetown in Washington, D.C.!
"I think what we're really seeing as a therapeutic platform emerging is particularly genome editing with the idea that...we're looking at an editor and a delivery system and applying that to more than one disease."
During this episode of Soundbites of the Annual Meeting, we spoke with P.J. Brooks, PhD, who is Deputy Director of the Division of Rare Diseases Research Innovation, part of the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH).
In his conversation with ASGCT's Communications Committee Chair, Lynnea Olivarez, Dr. Brooks talked about:
The impact of developing cell and gene therapies as platforms to treat more than one disease
Projects he's involved in that are working towards the platform approach
What's giving him hope right now about the future of the field
Listen and subscribe to the ASGCT Podcast Network so you don't miss any episodes!
Did you attend the 28th Annual Meeting?
Watch all sessions on demand on the virtual meeting platform through July 18!
CGTs for Cancer, In Vivo Editing & More
© 2000-2025 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico